Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Finance > Healthcare company Sanofi announces share buyback of up to 2 billion euros

Finance

Healthcare company Sanofi announces share buyback of up to 2 billion euros

Published by Global Banking and Finance Review

Posted on February 7, 2025

Featured image for article about Finance

PARIS (Reuters) - French healthcare company Sanofi announced on Friday a share buyback plan worth up to 2 billion euros ($2.1 billion), which would be done between now and the end of December.

($1 = 0.9640 euros)

(Reporting by Sudip Kar-Gupta; Editing by Jamie Freed)

More from Finance

Explore more articles in the Finance category

Germany removes dividend ban for Uniper, paving way for IPO

Golden Goose gets new majority owner as China's HSG buys stake from Permira

Rubio says not concerned about escalation with Russia over Venezuela

ECB's Escriva expects monetary policy to remain steady

French government to appeal court ruling on Shein

Russian central bank governor Nabiullina speaks after rate cut

Strategy and bitcoin-buying firms face wider exclusion from stock indexes

Carnival Corp sees strong annual profit, resumes dividend as bookings rise

London's FTSE 100 climbs as miners, defence outperform in data-heavy week

Italy sells digital payment unit PagoPA to Poste, state mint for up to 500 million euros

Court in Brazil's Minas Gerais slaps down Nestle copyright lawsuit

German court jails man for drugging, raping wife, posting assaults online

View All Finance Posts